A Call to Investigate IL-17 as Drug Target for Lung Cancer, COVID-19
Interleukin 17 may be a therapeutic target worth investigating for patients with lung cancer and SARS-CoV-2 infection, existing literature suggests.
Christina Bennett, MS
Christina Bennett, MS, is an independent medical journalist who writes about a variety of medical topics, including oncology, health care policy, and cell and gene therapies. She has a bachelor's degree in biomedical science and a master’s degree in science and technology journalism, both from Texas A&M University. She is a member of the Association of Healthcare Journalists and the National Association of Science Writers and was one of a dozen journalists selected for the 2017 National Cancer Reporting Fellowships.
